Influenza Vaccine Postpartum Questionnaire

This study has been completed.
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto Identifier:
First received: November 17, 2006
Last updated: April 22, 2016
Last verified: April 2016
The purpose of this trial is to assess the knowledge and attitudes of post-partum women regarding influenza and the use of the influenza vaccine in pregnancy.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Acceptability and Feasibility of Influenza Vaccine Administration on the Post-partum Floor Prior to Discharge Home During Flu Season

Resource links provided by NLM:

Further study details as provided by St. Michael's Hospital, Toronto:

Enrollment: 150
Study Start Date: October 2006
Study Completion Date: July 2009
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Detailed Description:
Women on our post-partum floor will be approached to complete a questionnaire which will assess their knowledge and attitudes regarding influenza and the use of the influenza vaccine in pregnancy. The study will take place over a 2-month period during influenza season, and at the time when the influenza vaccine becomes available.

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
pregnant women

Inclusion Criteria:

  • women admitted to the postpartum floor during the study period

Exclusion Criteria:

  • inability to read or understand English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00401700

Canada, Ontario
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Principal Investigator: Mark H Yudin, MD, MSc St. Michael's Hospital, Toronto, Canada
  More Information

Responsible Party: St. Michael's Hospital, Toronto Identifier: NCT00401700     History of Changes
Other Study ID Numbers: fluvaccinesmh 
Study First Received: November 17, 2006
Last Updated: April 22, 2016
Health Authority: Canada: Ethics Review Committee

Keywords provided by St. Michael's Hospital, Toronto:
influenza vaccine

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Respiratory Tract Diseases
Respiratory Tract Infections
Virus Diseases processed this record on May 26, 2016